Moran Sean F.

Average Profitability
30.87%
Insider Buys Quantity
46
Insider Buys Sum
$1.21M
Insider Sells Quantity
6
Insider Sells Sum
$1.06M

Insider Activity of Moran Sean F.

According to the SEC Form 4 filings, Moran Sean F., being in a position of

  1. Chief Financial Officer at Corbus Pharmaceuticals Holdings, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 16476 shares for $785,685,
    over all time since 2014-11-25, has bought 396660 shares for $1.2M, and sold 194509 shares for $1.06M.

The largest purchase of all time was on 2016-08-17 and amounted to 83960 shares of Corbus Pharmaceuticals Holdings, Inc. for $267,832.

The largest sale of all time was on 2024-06-14 and amounted to 7788 shares of Corbus Pharmaceuticals Holdings, Inc. for $388,417.

Biography of Moran Sean F.

No biography is available at this moment.

2024-06-18SaleCorbus Pharmaceuticals Holdings, Inc.
CRBP
Chief Financial Officer
1,958
0.038%
$42.12$82,479-3.04%
2024-06-17SaleCorbus Pharmaceuticals Holdings, Inc.
CRBP
Chief Financial Officer
6,730
0.145%
$46.77$314,789-3.7%
2024-06-14SaleCorbus Pharmaceuticals Holdings, Inc.
CRBP
Chief Financial Officer
7,788
0.179%
$49.87$388,417-14.83%
2022-08-10PurchaseCorbus Pharmaceuticals Holdings, Inc.
CRBP
Chief Financial Officer
20,000
0.0024%
$0.26$5,198-23.53%
2022-05-16PurchaseCorbus Pharmaceuticals Holdings, Inc.
CRBP
Chief Financial Officer
12,000
0.0017%
$0.30$3,600-34.56%
2022-03-10PurchaseCorbus Pharmaceuticals Holdings, Inc.
CRBP
Chief Financial Officer
15,000
0.0026%
$0.37$5,550-46.84%
2020-12-21SaleCorbus Pharmaceuticals Holdings, Inc.
CRBP
Chief Financial Officer
87,500
0.0706%
$1.75$153,125-0.66%
2020-12-18SaleCorbus Pharmaceuticals Holdings, Inc.
CRBP
Chief Financial Officer
53,610
0.0346%
$1.40$75,054+1.33%
2020-12-16SaleCorbus Pharmaceuticals Holdings, Inc.
CRBP
Chief Financial Officer
36,923
0.0224%
$1.32$48,628+16.03%
2019-05-14PurchaseCorbus Pharmaceuticals Holdings, Inc.
CRBP
Chief Financial Officer
100
0.0003%
$7.12$712-21.67%
2019-03-14PurchaseCorbus Pharmaceuticals Holdings, Inc.
CRBP
Chief Financial Officer
1,500
0.0046%
$6.67$10,005-14.71%
2018-05-15PurchaseCorbus Pharmaceuticals Holdings, Inc.
CRBP
Chief Financial Officer
4,000
0.0106%
$5.77$23,080+5.24%
2018-03-14PurchaseCorbus Pharmaceuticals Holdings, Inc.
CRBP
Chief Financial Officer
3,100
0.0094%
$6.60$20,460-8.82%
2017-11-10PurchaseCorbus Pharmaceuticals Holdings, Inc.
CRBP
Chief Financial Officer
1,500
0.0049%
$7.04$10,560-8.97%
2017-08-11PurchaseCorbus Pharmaceuticals Holdings, Inc.
CRBP
Chief Financial Officer
2,500
0.0068%
$5.91$14,775+9.24%
2017-05-11PurchaseCorbus Pharmaceuticals Holdings, Inc.
CRBP
Chief Financial Officer
3,300
0.0093%
$6.14$20,262+10.57%
2017-03-13PurchaseCorbus Pharmaceuticals Holdings, Inc.
CRBP
Chief Financial Officer
2,000
0.0088%
$9.60$19,200-27.37%
2016-12-02PurchaseCorbus Pharmaceuticals Holdings, Inc.
CRBP
Chief Financial Officer
1,500
0.005%
$7.20$10,800-4.17%
2016-09-08PurchaseCorbus Pharmaceuticals Holdings, Inc.
CRBP
Chief Financial Officer
30,800
0.0727%
$5.12$157,696+32.69%
2016-08-26PurchaseCorbus Pharmaceuticals Holdings, Inc.
CRBP
Chief Financial Officer
17,900
0.0323%
$3.92$70,168+59.67%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.